Combining chemotherapy with PD-1 blockade in NSCLC
Year: 2018
Type: review
Source: Pharmacology & Therapeutics
Institution: Columbia University Irving Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Amgen
OpenAlex ID: W2792286951
